138 related articles for article (PubMed ID: 3112380)
1. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
Bendig JW; Kyle PW; Giangrande PL; Samson DM; Azadian BS
J R Soc Med; 1987 May; 80(5):316-7. PubMed ID: 3112380
[No Abstract] [Full Text] [Related]
2. Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
Ulrich E; Trautmann M; Krause B; Bauernfeind A; Hahn H
Infection; 1989; 17(5):311-5. PubMed ID: 2599653
[TBL] [Abstract][Full Text] [Related]
3. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients.
Verhagen C; de Pauw BE; Donnelly JP; Williams KJ; de Witte T; Janssen TH
J Infect; 1986 Sep; 13(2):125-31. PubMed ID: 3093589
[TBL] [Abstract][Full Text] [Related]
4. Letter: Pseudomonas septicaemia following superficial colonization.
Spiers AS
Br Med J; 1974 Dec; 4(5947):770. PubMed ID: 4216391
[No Abstract] [Full Text] [Related]
5. Indications for systemic antibiotic prophylaxis in neutropenic patients.
Spiers AS; Tattersall MH; Gaya H
Br Med J; 1974 Nov; 4(5942):440-1. PubMed ID: 4214579
[TBL] [Abstract][Full Text] [Related]
6. Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Gordin FM; Hackbarth CJ; Scott KG; Sande MA
Antimicrob Agents Chemother; 1985 Apr; 27(4):452-4. PubMed ID: 3159336
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
Fu KP; Hetzel N; Gregory FJ; Hung PP
J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of Pseudomonas aeruginosa septicaemia and meningitis with neutropenia--the presenting feature of hypogammaglobulinaemia.
Johnston PG; Speller DC
Postgrad Med J; 1977 Jun; 53(620):334-7. PubMed ID: 887532
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and therapeutic features of pseudomonas aeruginosa septicaemia].
Helm E; Stille W
Dtsch Med Wochenschr; 1972 Oct; 97(42):1584-9. PubMed ID: 4116663
[No Abstract] [Full Text] [Related]
10. Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
Chaudhry NA; Tabandeh H; Rosenfeld PJ; Miller D; Davis J
Arch Ophthalmol; 1998 Sep; 116(9):1251. PubMed ID: 9747696
[No Abstract] [Full Text] [Related]
11. Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.
Scott RE; Robson HG
Antimicrob Agents Chemother; 1976 Oct; 10(4):646-51. PubMed ID: 825035
[TBL] [Abstract][Full Text] [Related]
12. Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis.
Mannan P; Kibbler CC; Noone P
J Antimicrob Chemother; 1988 Dec; 22(6):953-4. PubMed ID: 3149635
[No Abstract] [Full Text] [Related]
13. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
Opal SM; Cross AS; Kelly NM; Sadoff JC; Bodmer MW; Palardy JE; Victor GH
J Infect Dis; 1990 Jun; 161(6):1148-52. PubMed ID: 2140582
[TBL] [Abstract][Full Text] [Related]
15. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
[No Abstract] [Full Text] [Related]
16. Clostridium tertium septicemia in patients with neutropenia.
Speirs G; Warren RE; Rampling A
J Infect Dis; 1988 Dec; 158(6):1336-40. PubMed ID: 3198941
[TBL] [Abstract][Full Text] [Related]
17. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
[TBL] [Abstract][Full Text] [Related]
18. Empirical treatment of sepsis in neutropenic patients.
Klastersky J
Int J Antimicrob Agents; 2000 Oct; 16(2):131-3. PubMed ID: 11053794
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Johnson DE; Thompson B
Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
